Immunological alternation in COVID-19 patients with cancer and its implications on mortality

Immunological alternation in COVID-19 patients with cancer and its implications on mortality

Patients with malignancy were reportedly more susceptible and vulnerable to Coronavirus Disease 2019 (COVID-19), and witnessed a greater mortality risk in COVID-19 infection than noncancerous patients. But the role of immune dysregulation of malignant patients on poor prognosis of COVID-19 has remai...

Full description

Bibliographic Details
Main Authors: Guangyao Cai, Yue Gao, Shaoqing Zeng, Yang Yu, Xingyu Liu, Dan Liu, Ya Wang, Ruidi Yu, Aakash Desai, Chunrui Li, Qinglei Gao
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:OncoImmunology
Subjects:
covid-19
sars-cov-2
immune response
cancer
prognosis
mortality
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1854424

Internet

http://dx.doi.org/10.1080/2162402X.2020.1854424

Similar Items